Insight

Filippo Montemurro: Different dosage forms of hormone agonists in endocrine therapy

Photo of Filippo Montemurro taken from www.irccs.com

Oct 15, 2024, 13:10

Filippo Montemurro: Different dosage forms of hormone agonists in endocrine therapy

Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X:

“Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancer. Monthly or three-monthly injections?”

Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancer

Authors: Jinna Lin, Yiye Ouyang, Yudong Li, Liang Jin, Shunying Li, Yujie Liu, Yaping Yang, Qianfeng Shi, Mengdi Zhu, Zijie Cai, Jingru Wang, Nianqiu Liu, Yue Hu, Zongqi Wu, Mengzi Wu, Lok Lam Wong, Xiaoting Jiang, Qi Wang, Wang Yang, Qiang Liu.

breast cancer treatment cancer cancer therapy clinical oncology dosage forms endocrine therapy F. Hoffmann La Roche Filippo Montemurro gonadotropin-releasing hormone healthcare professionals hormone receptor-positive breast cancer Jingru Wang Jinna Lin Liang Jin Lok Lam Wong Medical Research Mengdi Zhu Mengzi Wu Nianqiu Liu OncoDaily Oncology patient care Qi Wang Qianfeng Shi Qiang Liu Shunying Li Wang Yang Xiaoting Jiang Yaping Yang Yiye Ouyang Yudong Li Yue Hu Yujie Liu Zijie Cai Zongqi Wu

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer